News

Home>News
News2020-07-17T11:41:26-04:00
Aug 102020

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board

August 10th, 2020|Categories: Featured, Investor News, News|Tags: , , , , , |

Furthering the Fight Against Covid-19 Internationally Jackson Center, PA, August 10, 2020 – Halberd Corp. (OTC PINK: "HALB") today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board.  Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences. Dr. Nanhay’s experiences include general medicine practice, emergency medicine, health management, and coordination of clinical research.  Dr. Nanhay also had worked for medical and educational ...

Aug 42020

Halberd Corporation Secures $2 Million for Covid-19 Research

August 4th, 2020|Categories: Featured, Investor News, News|Tags: , , , |

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s).  Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd Corporation and its research partners William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, “Securing this funding will ...

Jul 272020

Retired NFL Great Carl Eller Joins Halberd Corporation

July 27th, 2020|Categories: Featured, Investor News, News|Tags: , , , , , |

Will Assist with Covid-19 Efforts and the Brain Jackson Center, PA, July 27, 2020 – Halberd Corp. (OTC PINK: "HALB") announced the appointment of Carl Eller, retired NFL Pro Football Hall of Famer, and President of the NFL Retired Players Association as a consultant.  Mr. Eller’s expertise and contacts will be leveraged as part of Halberd Corporation’s work on brain injury caused by impact to the head (PTSD) and potential neurological changes associated with Covid-19.  ...

Jul 222020

Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19’s Effects on Neurological Functions

July 22nd, 2020|Categories: Featured, Investor News, News|Tags: , , , , , |

Jackson Center, PA, July 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes, presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance of Arizona, on “Covid-19 & the Nervous System; Neurological Complications That Can Result”.  Dr. Reyes has been requested to repeat this virtual event for the Arizona State Legislature at 2:30 PM (AZ Time) on Friday, ...

Jul 162020

Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology

July 16th, 2020|Categories: Featured, Investor News|Tags: , , , , , , |

Jackson Center, PA, July 16, 2020 – Halberd Corp. (OTC PINK: "HALB") intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e., Covid-19 target antigens). This will allow the virus to be seen and located, and allow for eradicating the fluorescent antibody-antigen complex by utilizing an energy burst from a nano-laser, with the removal of the ...

Jul 132020

Halberd Corp – Update July 13, 2020 – Addresses Certain Issues

July 13th, 2020|Categories: Featured, Investor News, News|Tags: , , , |

Jackson Center, PA, July 13, 2020 – Halberd Corp. (OTC PINK: "HALB") today issued a statement to clarify certain items within its charter regarding allowable debt.  There have been inaccurate rumors that have put the company in a negative light.  One of these is that the company intends to take on convertible debt. Nothing could be further from the truth. Halberd’s corporate charter prohibits it from issuing any kind of convertible financial instrument, debt or ...

Go to Top